Back
Ligand Pharmaceuticals Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
56
LGND
Ligand Pharmaceuticals
Last Price:
115.58
Seasonality Move:
10.42%
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
781.46
Seasonality Move:
14.2%
Buy
56
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $115.45. The Score for LGND is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $782.51. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $115.45
The current trend is moderately bullish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $782.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.22 | Buy |
| Relative Strength Index (14 RSI): | 52.97 | Buy |
| Chaikin Money Flow: | -109873 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.5 - 118.96) | Buy |
| Bollinger Bands (100): | (93.99 - 111.55) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -57.82 | Sell |
| Relative Strength Index (14 RSI): | 13.92 | Sell |
| Chaikin Money Flow: | -932953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (825.73 - 982.29) | Sell |
| Bollinger Bands (100): | (945.47 - 1158.45) | Sell |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.12 | Sell |
| 20-day SMA: | 113.75 | Buy |
| 50-day SMA: | 106.91 | Buy |
| 200-day SMA: | 90.04 | Buy |
| 8-day EMA: | 118.66 | Sell |
| 20-day EMA: | 114.59 | Buy |
| 50-day EMA: | 108.78 | Buy |
| 200-day EMA: | 93.47 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 816.56 | Sell |
| 20-day SMA: | 877.34 | Sell |
| 50-day SMA: | 995.77 | Sell |
| 200-day SMA: | 1007.21 | Sell |
| 8-day EMA: | 819.7 | Sell |
| 20-day EMA: | 872.08 | Sell |
| 50-day EMA: | 958.25 | Sell |
| 200-day EMA: | 987.42 | Sell |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.38 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.37 per share, and an increase next year of $0.59 per share.
Ligand Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||